Although ISRG stock trades at a higher valuation of 13x trailing revenues, compared to just 5x for Stryker, this gap in valuation makes sense, in our view, given Intuitive Surgical’s superior revenue growth, profitability, and financial position, as discussed below Looking at stock returns, SYK, …
